Effects of Exercise on Arterial Function and Insulin Resistance Syndrome in Pre-pubertal Obese Children
- Conditions
- Obesity
- Interventions
- Behavioral: Exercise
- Registration Number
- NCT00801645
- Lead Sponsor
- University Hospital, Geneva
- Brief Summary
The main purpose of this project is to investigate the effects of an exercise program on arterial function and cardiovascular diseases risk factors in obese and lean pre-pubertal children. This information will be used to underpin prevention strategies to reduce cardiovascular diseases in overweight youth.
- Detailed Description
Introduction: cardiovascular diseases (CVD) are the major contributor to the global burden of non-communicable diseases, one third of all global death being attributed to CVD. Childhood obesity poses a major public health problem and there is increasing evidence that foundation of cardiovascular diseases lays early in life in obese children. There is therefore an urgent need to identify effective prevention strategies. Physical activity is recognized as major determinants of cardiovascular health in adults and adolescents however, little is known in young children. The main purpose of this project is to investigate the effects of a 3-month exercise training program on arterial function and cardiovascular diseases risk factors in obese and lean children.
Methods: This is a randomized controlled trial including 4 groups of pre-pubertal children aged 6 to 11 years old: 1) obese exercise, 2) obese control, 3) lean exercise, and 4) lean control. The exercise groups engage in aerobic exercise training three 60-minute sessions per week for 12 weeks, in addition of school physical education. Training sessions consist of 30 minutes of aerobic exercise (walking, running, games, swimming), followed by strength training and stretching. Controls are relatively inactive. After the 3-month intervention, the obese control group engages in an identical 12-week exercise program and the obese exercise group is encouraged to continue for a total of 6 months. Primary measures include: 24-hour ambulatory systolic and diastolic blood pressure; endothelial function and mechanical indices of the brachial and carotid arteries using a B-mode ultrasound imager; central blood pressure and pulse wave velocity by tonometry of aplanation. Other measures include: body composition, physical activity, cardio-respiratory fitness, nutrition, quality of life, and fasting blood lipids, insulin, glucose, markers of vascular function and inflammation. Testing is performed at baseline, 3, 6 and 24 months in obese children and at baseline and 3 months in lean children.
We hypothesize that exercise training will result in improved arterial function, body composition and markers of the metabolic syndrome in obese children. This information will be used to underpin prevention strategies to reduce CVD risk factors in this high-risk population.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 67
- obese children: Pre-pubertal (Tanner stage 1), BMI > 97th age- and gender-specific percentile (Kromeyer-Hauschild et al. 2001).
- lean subjects: Pre-pubertal (Tanner stage 1), BMI > 10th and < 90th age- and gender-specific percentile.
- being involved in any weight control, physical activity, or behavioral therapy
- familial history of dyslipidemia or essential hypertension
- medications or hormones, which may influence cardiovascular function, body composition, lipid or glucose metabolism
- orthopedic affection limiting physical activity
- genetic disorder or a chronic disease
- following a therapy for psychiatric problems
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Obese exercise Exercise - Lean Exercise Exercise -
- Primary Outcome Measures
Name Time Method Arterial function 0-3-6-24 months
- Secondary Outcome Measures
Name Time Method Body composition 0-3-6-24 months Body mass index 0-3-6-24 months Cardiorespiratory fitness 0-3-6-24 months Physical activity 0-3-6-24 months Insulin resistance 0-3-6-24 months Blood lipids 0-3-6-24 months Biological markers of endothelial function 0-3-6-24 months High sensitive C-reactive protein 0-3-6-24 months Resting and ambulatory blood pressure 0-3-6-24 months
Trial Locations
- Locations (1)
Department of Child and Adolescent, University Hospital of Geneva
🇨ðŸ‡Geneva, Switzerland